$5.32
-0.06-1.12%
At close: Nov 13, 4:00 PM EST
$5.40
0.081.5%
After Hours: Nov 13, 5:46 PM EST
RxSight Inc
RXSTNASDAQ
RxSight fell 45.3% from $9.73 to $5.32, behind the S&P 500's +12.3%. Its worst day was May 7 (−14.5%), and its low came Oct 16 at $4.51.
Story events cover the past 12 months · Times ET
Nov 14, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
RxSight shares rose 13.4%, while the S&P 500 rose 1.0%.
+13.4% · S&P 500 +1.0%
RxSight closed at its highest level of the year, 34.5% above where the year started.
+4.0% · S&P 500 +0.2%
RxSight shares rose 14.1%, while the S&P 500 rose 0.2%.
+14.1%, the year's best day · S&P 500 +0.2%
EPS of $-0.03 beat the $-0.28 estimate on $32.6M revenue (est. $32.6M); FY revenue guidance of $120.0M–$135.0M against the $135.4M consensus.
−10.1% · S&P 500 −0.6%
EPS of $-0.19 missed the $-0.16 estimate on $30.9M revenue (est. $29.7M); FY revenue guidance of $120.0M–$135.0M against the $129.1M consensus.
−14.5%, the year's worst day · S&P 500 −0.3%
EPS of $-0.11 beat the $-0.23 estimate on $33.7M revenue (est. $32.1M).
−3.3% · S&P 500 −0.2%
RxSight closed at its lowest level of the year, 53.6% below where the year started.
−3.4% · S&P 500 −1.1%
EPS of $-0.21 beat the $-0.23 estimate on $24.6M revenue (est. $27.3M).
+8.7% · S&P 500 +1.7%
Where it ended: a close of $5.32 on Nov 13, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $0.36, revenue est. $57.6M).
Nothing in the past 12 months.
All RXST dividend history
